Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Washington scientists link apoE to a major cause of bleeding strokes

June 8, 2000

Neuroprotective substance found in tobacco

June 8, 2000

Calcium channel blockers in development at Questcor as neuroprotective agents

June 7, 2000

NDA submitted for fast-dissolving Zomig

June 7, 2000

Pyrazolopyridine adenosine antagonists, their activity and use described by Fujisawa

June 6, 2000

New N-type calcium channel blockers synthesized at Ajinomoto

June 6, 2000

New Snow Brand compounds inhibit neuronal apoptosis

June 6, 2000

American Biogenetic Sciences to accelerate ABS-205 development for AD

June 6, 2000

The corticotropin-releasing factor receptor antagonist antalarmin reduces stress in monkeys

June 6, 2000

IGT Pharma compound neuroprotective in vitro

June 5, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...